most effective glp-1 drug Agonists Explained: Definition, How They Work, Side Effects List of approved and pending

Description

However, it's important to note that many of these studies are observational and do not prove that GLP-1 medications cause the reduced risk

Fatigue is another commonly reported experience, particularly during the first weeks of treatment or after dose increases

Lastly, GLP-1 induces the maintenance of glial cells, such as Mller glia, by downregulating the reactivity of astrocytes

Koh B, Xiao J, Ng CH, et al

Soliqua 100/33 (active ingredients: insulin glargine and lixisenatide) subcutaneous injection Initial FDA Approval: 2016 Side Effect Update Date: May 28, 2025 Medication Description: Treats type 2 diabetes Updated Side Effects/Safety Information: A new warning section on Severe Gastrointestinal Adverse Reactions. An additional new warning about the risk of serious kidney injury caused by dehydration due to gastrointestinal adverse effects like diarrhea and vomiting